Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps

•This study identified higher serologic levels of ADAMTS12 in patients with Eps.•The study identified ADAMTS12 as a useful biological marker for predicting the occurrence and their recurrence of EPs.•It may provide new ideas for the subsequent development of drugs to treat EPs and prevent their recu...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2024-04, Vol.295, p.86-91
Main Authors: Nian, Jiejie, Zhu, Yuqing, Lv, Xiaoli, Zhang, Yue, Xue, Zhongkai, Wu, Zhongran, Zhou, Yujia, Liu, Yu
Format: Article
Language:English
Subjects:
ADAMTS proteases
Endometrial polyps
Endometriotic diseases
Extracellular matrix
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c357t-b2766e0499388fba9112c87f5c3902b8722ad589e967b00a62295fd6f6176af3
container_end_page 91
container_issue
container_start_page 86
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 295
creator Nian, Jiejie
Zhu, Yuqing
Lv, Xiaoli
Zhang, Yue
Xue, Zhongkai
Wu, Zhongran
Zhou, Yujia
Liu, Yu
description •This study identified higher serologic levels of ADAMTS12 in patients with Eps.•The study identified ADAMTS12 as a useful biological marker for predicting the occurrence and their recurrence of EPs.•It may provide new ideas for the subsequent development of drugs to treat EPs and prevent their recurrence. Endometrial polyps (EPs) are common gynecological disorders for which no clear etiology has been found. ADAMTS have been associated with a variety of diseases. This study aimed to investigate the potential correlation between serologic levels of ADAMTS 5, 9, and 12 in patients with EPs. A total of 88 patients were categorized into two groups: the EPs group, consisting of recurrent EPs and first occurrence EPs, and a control group. The study compared the general information and serum levels of ADAMTS 5, 9, and 12 between the groups. Regarding the general data, a statistically significant age difference (p 
doi_str_mv 10.1016/j.ejogrb.2024.02.008
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2925033943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211524000563</els_id><sourcerecordid>2925033943</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-b2766e0499388fba9112c87f5c3902b8722ad589e967b00a62295fd6f6176af3</originalsourceid><addsrcrecordid>eNp9kc2O1DAQhC0EYoeFN0DIRw6b4J_YiS9Io2X5kRZxYO6WY7cXjzJxsJMR-xY8Mg5ZuCDRlz50dZX0FUIvKakpofLNsYZjvEt9zQhrasJqQrpHaEe7llWtFM1jtCOc0IpRKi7Qs5yPpAzn6im64B1viFBih37e_JgS5BziiAc4w5Bx9Hj_bv_58BWLK6yusBkdpgyHEcPo4gnmFMyApzjcT_n3cf4GIeFi44Kdwxnw2QwLYB_TesIumLsx5rCJE9glJRgtrEH_Oj5HT7wZMrx42Jfo8P7mcP2xuv3y4dP1_rayXLRz1bNWSiCNUrzrfG8Upcx2rReWK8L6AoEZJzoFSrY9IUYypoR30kvaSuP5JXq92U4pfl8gz_oUsoVhMCPEJWummFhhNbxIm01qU8w5gddTCieT7jUleq1CH_VWhV6r0ITpUkV5e_WQsPQncH-f_rAvgreboECHc4Cksw0rGBcKpFm7GP6f8AslcZwi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925033943</pqid></control><display><type>article</type><title>Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps</title><source>ScienceDirect Freedom Collection</source><creator>Nian, Jiejie ; Zhu, Yuqing ; Lv, Xiaoli ; Zhang, Yue ; Xue, Zhongkai ; Wu, Zhongran ; Zhou, Yujia ; Liu, Yu</creator><creatorcontrib>Nian, Jiejie ; Zhu, Yuqing ; Lv, Xiaoli ; Zhang, Yue ; Xue, Zhongkai ; Wu, Zhongran ; Zhou, Yujia ; Liu, Yu</creatorcontrib><description>•This study identified higher serologic levels of ADAMTS12 in patients with Eps.•The study identified ADAMTS12 as a useful biological marker for predicting the occurrence and their recurrence of EPs.•It may provide new ideas for the subsequent development of drugs to treat EPs and prevent their recurrence. Endometrial polyps (EPs) are common gynecological disorders for which no clear etiology has been found. ADAMTS have been associated with a variety of diseases. This study aimed to investigate the potential correlation between serologic levels of ADAMTS 5, 9, and 12 in patients with EPs. A total of 88 patients were categorized into two groups: the EPs group, consisting of recurrent EPs and first occurrence EPs, and a control group. The study compared the general information and serum levels of ADAMTS 5, 9, and 12 between the groups. Regarding the general data, a statistically significant age difference (p &lt; 0.05) was observed, while no significant differences were found in the other variables. After considering age as a confounding factor, the previously observed statistical significance in the differences of ADAMTS5 and 9 between the groups diminished. However, it was found that the concentrations of ADAMTS12 in both the EPs group and the recurrent EPs group were significantly higher compared to the control group and the first occurrence EPs group (p &lt; 0.05). ROC curves were generated to determine the critical values of ADAMTS12 for predicting EPs and recurrent EPs, which were found to be 0.6962 ng/ml (sensitivity: 100 %, specificity: 39.5 %) and 0.8768 ng/ml (sensitivity: 75.0 %, specificity: 76.3 %), respectively. Our findings revealed elevated serologic levels of ADAMTS12 in the EPs group, particularly in the recurrent EPs group. Furthermore, ADAMTS-12 was identified as a valuable biomarker for assisting in the diagnosis and prediction of EPs recurrence.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2024.02.008</identifier><identifier>PMID: 38340595</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>ADAMTS proteases ; Endometrial polyps ; Endometriotic diseases ; Extracellular matrix</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2024-04, Vol.295, p.86-91</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c357t-b2766e0499388fba9112c87f5c3902b8722ad589e967b00a62295fd6f6176af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38340595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nian, Jiejie</creatorcontrib><creatorcontrib>Zhu, Yuqing</creatorcontrib><creatorcontrib>Lv, Xiaoli</creatorcontrib><creatorcontrib>Zhang, Yue</creatorcontrib><creatorcontrib>Xue, Zhongkai</creatorcontrib><creatorcontrib>Wu, Zhongran</creatorcontrib><creatorcontrib>Zhou, Yujia</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><title>Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>•This study identified higher serologic levels of ADAMTS12 in patients with Eps.•The study identified ADAMTS12 as a useful biological marker for predicting the occurrence and their recurrence of EPs.•It may provide new ideas for the subsequent development of drugs to treat EPs and prevent their recurrence. Endometrial polyps (EPs) are common gynecological disorders for which no clear etiology has been found. ADAMTS have been associated with a variety of diseases. This study aimed to investigate the potential correlation between serologic levels of ADAMTS 5, 9, and 12 in patients with EPs. A total of 88 patients were categorized into two groups: the EPs group, consisting of recurrent EPs and first occurrence EPs, and a control group. The study compared the general information and serum levels of ADAMTS 5, 9, and 12 between the groups. Regarding the general data, a statistically significant age difference (p &lt; 0.05) was observed, while no significant differences were found in the other variables. After considering age as a confounding factor, the previously observed statistical significance in the differences of ADAMTS5 and 9 between the groups diminished. However, it was found that the concentrations of ADAMTS12 in both the EPs group and the recurrent EPs group were significantly higher compared to the control group and the first occurrence EPs group (p &lt; 0.05). ROC curves were generated to determine the critical values of ADAMTS12 for predicting EPs and recurrent EPs, which were found to be 0.6962 ng/ml (sensitivity: 100 %, specificity: 39.5 %) and 0.8768 ng/ml (sensitivity: 75.0 %, specificity: 76.3 %), respectively. Our findings revealed elevated serologic levels of ADAMTS12 in the EPs group, particularly in the recurrent EPs group. Furthermore, ADAMTS-12 was identified as a valuable biomarker for assisting in the diagnosis and prediction of EPs recurrence.</description><subject>ADAMTS proteases</subject><subject>Endometrial polyps</subject><subject>Endometriotic diseases</subject><subject>Extracellular matrix</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc2O1DAQhC0EYoeFN0DIRw6b4J_YiS9Io2X5kRZxYO6WY7cXjzJxsJMR-xY8Mg5ZuCDRlz50dZX0FUIvKakpofLNsYZjvEt9zQhrasJqQrpHaEe7llWtFM1jtCOc0IpRKi7Qs5yPpAzn6im64B1viFBih37e_JgS5BziiAc4w5Bx9Hj_bv_58BWLK6yusBkdpgyHEcPo4gnmFMyApzjcT_n3cf4GIeFi44Kdwxnw2QwLYB_TesIumLsx5rCJE9glJRgtrEH_Oj5HT7wZMrx42Jfo8P7mcP2xuv3y4dP1_rayXLRz1bNWSiCNUrzrfG8Upcx2rReWK8L6AoEZJzoFSrY9IUYypoR30kvaSuP5JXq92U4pfl8gz_oUsoVhMCPEJWummFhhNbxIm01qU8w5gddTCieT7jUleq1CH_VWhV6r0ITpUkV5e_WQsPQncH-f_rAvgreboECHc4Cksw0rGBcKpFm7GP6f8AslcZwi</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Nian, Jiejie</creator><creator>Zhu, Yuqing</creator><creator>Lv, Xiaoli</creator><creator>Zhang, Yue</creator><creator>Xue, Zhongkai</creator><creator>Wu, Zhongran</creator><creator>Zhou, Yujia</creator><creator>Liu, Yu</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240401</creationdate><title>Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps</title><author>Nian, Jiejie ; Zhu, Yuqing ; Lv, Xiaoli ; Zhang, Yue ; Xue, Zhongkai ; Wu, Zhongran ; Zhou, Yujia ; Liu, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-b2766e0499388fba9112c87f5c3902b8722ad589e967b00a62295fd6f6176af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ADAMTS proteases</topic><topic>Endometrial polyps</topic><topic>Endometriotic diseases</topic><topic>Extracellular matrix</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nian, Jiejie</creatorcontrib><creatorcontrib>Zhu, Yuqing</creatorcontrib><creatorcontrib>Lv, Xiaoli</creatorcontrib><creatorcontrib>Zhang, Yue</creatorcontrib><creatorcontrib>Xue, Zhongkai</creatorcontrib><creatorcontrib>Wu, Zhongran</creatorcontrib><creatorcontrib>Zhou, Yujia</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nian, Jiejie</au><au>Zhu, Yuqing</au><au>Lv, Xiaoli</au><au>Zhang, Yue</au><au>Xue, Zhongkai</au><au>Wu, Zhongran</au><au>Zhou, Yujia</au><au>Liu, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>295</volume><spage>86</spage><epage>91</epage><pages>86-91</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>•This study identified higher serologic levels of ADAMTS12 in patients with Eps.•The study identified ADAMTS12 as a useful biological marker for predicting the occurrence and their recurrence of EPs.•It may provide new ideas for the subsequent development of drugs to treat EPs and prevent their recurrence. Endometrial polyps (EPs) are common gynecological disorders for which no clear etiology has been found. ADAMTS have been associated with a variety of diseases. This study aimed to investigate the potential correlation between serologic levels of ADAMTS 5, 9, and 12 in patients with EPs. A total of 88 patients were categorized into two groups: the EPs group, consisting of recurrent EPs and first occurrence EPs, and a control group. The study compared the general information and serum levels of ADAMTS 5, 9, and 12 between the groups. Regarding the general data, a statistically significant age difference (p &lt; 0.05) was observed, while no significant differences were found in the other variables. After considering age as a confounding factor, the previously observed statistical significance in the differences of ADAMTS5 and 9 between the groups diminished. However, it was found that the concentrations of ADAMTS12 in both the EPs group and the recurrent EPs group were significantly higher compared to the control group and the first occurrence EPs group (p &lt; 0.05). ROC curves were generated to determine the critical values of ADAMTS12 for predicting EPs and recurrent EPs, which were found to be 0.6962 ng/ml (sensitivity: 100 %, specificity: 39.5 %) and 0.8768 ng/ml (sensitivity: 75.0 %, specificity: 76.3 %), respectively. Our findings revealed elevated serologic levels of ADAMTS12 in the EPs group, particularly in the recurrent EPs group. Furthermore, ADAMTS-12 was identified as a valuable biomarker for assisting in the diagnosis and prediction of EPs recurrence.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38340595</pmid><doi>10.1016/j.ejogrb.2024.02.008</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2024-04, Vol.295, p.86-91
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_2925033943
source ScienceDirect Freedom Collection
subjects ADAMTS proteases
Endometrial polyps
Endometriotic diseases
Extracellular matrix
title Expression levels of ADAMTS 5, 9, and 12 in endometrial polyps and their predictive value for the diagnosis and recurrence of endometrial polyps
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A47%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20levels%20of%20ADAMTS%205,%209,%20and%2012%20in%20endometrial%20polyps%20and%20their%20predictive%20value%20for%20the%20diagnosis%20and%20recurrence%20of%20endometrial%20polyps&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Nian,%20Jiejie&rft.date=2024-04-01&rft.volume=295&rft.spage=86&rft.epage=91&rft.pages=86-91&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2024.02.008&rft_dat=%3Cproquest_cross%3E2925033943%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-b2766e0499388fba9112c87f5c3902b8722ad589e967b00a62295fd6f6176af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2925033943&rft_id=info:pmid/38340595&rfr_iscdi=true